|
Ampicillin
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
10 |
|
30 |
| Conventional |
8 |
|
33 |
|
|
Ampicillin And Beta-Lactamase Inhibitor
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
4 |
|
30 |
| Conventional |
6 |
|
33 |
|
|
Cefazolin
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
13 |
|
30 |
| Conventional |
10 |
|
33 |
|
|
Cefoxitin
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
3 |
|
30 |
| Conventional |
1 |
|
33 |
|
|
Ceftriaxone
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
2 |
|
30 |
| Conventional |
1 |
|
33 |
|
|
Ciprofloxacin
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
0 |
|
30 |
| Conventional |
0 |
|
33 |
|
|
Nalidixic Acid
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
1 |
|
30 |
| Conventional |
1 |
|
33 |
|
|
Gentamicin
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
4 |
|
30 |
| Conventional |
8 |
|
33 |
|
|
Amikacin
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
0 |
|
30 |
| Conventional |
0 |
|
33 |
|
|
Tetracycline
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
9 |
|
30 |
| Conventional |
10 |
|
33 |
|
|
Sulfamethoxazole And Trimethoprim
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
0 |
|
30 |
| Conventional |
3 |
|
33 |
|
|
Imipenem And Cilastatin
/
|
Escherichia coli
|
| See: Supplementary data/Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| organic |
0 |
|
30 |
| Conventional |
0 |
|
33 |
|